Searched for
PHARMACEUTICAL BENEFITS SCHEME
Strong balance sheets help India Inc absorb West Asia fallout: CrisilA stress test by Crisil Ratings covering 34 sectors that account for 65% of its rated corporate debt suggests that India Inc remains broadl...- 75 Indian students awarded Erasmus+ scholarships; EU-India Student Ambassadors' Network launchedThe EU has launched a new Student Ambassadors' Network involving 40 students from 20 Indian universities to promote European academic and r...
- NFO Alert: Tata Mutual Fund announces launch of Tata Multi-sector Passive FoFTata Mutual Fund has launched the Tata Multi-sector Passive FoF, an open-ended scheme investing in passive equity funds across various sect...
- India-UK free trade deal to take effect on July 15, opening 99% of exports to tariff-free accessIndia and the UK's Comprehensive Economic and Trade Agreement (CETA) will take effect on July 15, granting 99% of Indian exports tariff-fre...
- ETMarkets Smart Talk | Defence and electrification are multi-year structural themes for India: Prateek AgrawalGeopolitical shifts and the drive for self-reliance are creating long-term investment opportunities in India's defence and electrification ...
- Why a Rs 72,000 crore fund manager refuses to chase defence rally nowICICI Prudential's Mittul Kalawadia advises caution on current market valuations. He notes that future growth is already factored into stoc...
- India attracted $843 billion in FDI between 2014-15 and 2025-26: OfficialIndia has seen a significant rise in Foreign Direct Investment, attracting USD 843 billion between 2014-15 and 2025-26. Key government init...
- 12 years of PM Modi: Bold reforms, decisive decisions and political turning pointsAfter 12 years at the helm, Prime Minister Narendra Modi reflects on a transformative journey filled with key reforms that have altered Ind...
- Vegetable prices skyrocketed during Modi Govt's tenure: Telanagana CM Revanth ReddyTelangana Chief Minister Revanth Reddy inaugurated a new fruit market and sub-registrar office complex. He criticized the central governmen...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...
- India’s 'China-plus-one' push needs tax ease and fast-track FTAs with developed nations: Arvind VirmaniIndia must reform its tax system and streamline clearances to attract global investments moving away from China. Economist Arvind Virmani e...
- India labour market remodels itself bit by bit as agri slowly cedes ground, workforce moves onIndia's labour market is undergoing a structural transformation driven by the country's broader economic transition, a report by SBI Resear...
- India to solidify partnership with Africa at high-stakes summitIndia is set to host a significant summit on May 31 to strengthen its partnership with African nations. The meeting will focus on enhancing...
- War, oil price hikes, and risks: Time to still be contrarian? 5 small-caps from different sectors with upside potential of up to 25%Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...
- IMEC momentum to boost Karnataka exports amid global trade disruptionsBengaluru exporters are poised to thrive as the India-Middle East-Europe Economic Corridor gains traction. This innovative route presents a...
- India seen to line up three buffers for its economy amid the Iran storm: Fitch unitIran War: The Indian government is seen to focus on securing essential supplies, curbing business costs through subsidies and tax relief, a...
- Wegovy edges closer to PBS listing in Australia for high-risk obesity patientsA key Australian health committee has recommended Wegovy for subsidized access. This drug targets adults with existing heart conditions and...
- Government likely to extend export benefits under RoDTEP scheme for pharma, steel, chemical sectors"As exports are not doing good for the last few months, there is a demand to extend it for about six months till March 2024. It is under co...
- Govt launches three schemes for pharma sector MSMEsThe Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS) would facilitate pharmaceutical MSMEs with proven track record to upgra...
- Biocon, Mylan launch insulin biosimilar in AustraliaThe biotechnology major and pharmaceutical company Mylan N V announced the launch of their insulin biosimilar Semglee.
Load More
